Evidence map›Paper›PMID 39056736›Full record

ArticleBiology2024

The Therapeutic Potential of

Sheng Qin, Jiayi Fang, Xin He, Genfa Yu, Fengping Yi, Guangyong Zhu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sheng QinDepartment of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai 201418, China.
Jiayi FangDepartment of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai 201418, China.ORCID 0009-0002-2318-1265
Xin HeDepartment of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai 201418, China.
Genfa YuDepartment of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai 201418, China.
Fengping YiDepartment of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai 201418, China.
Guangyong ZhuDepartment of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai 201418, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder that is projected by the WHO to affect over 100 million people by 2050. Clinically, AD patients undergoing long-term antipsychotic treatment often experience severe anxiety or depression in later stages. Furthermore, early-stage AD manifests with weakened α waves in the brain, progressing to diminished α and β waves in late-stage disease, reflecting changes in emotional states and disease progression. In this study, EEG signal analysis revealed that inhalation of

Indexed as

Alzheimer’s diseaseDalbergia pinnataelectroencephalographyessential oilnetwork pharmacologySH-SY5Y cell

Identifiers

PMID39056736
PMCPMC11274073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.